SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-20-286283
Filing Date
2020-11-05
Accepted
2020-11-05 08:20:19
Documents
48
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d83873d10q.htm   iXBRL 10-Q 1609143
2 EX-10.1 d83873dex101.htm EX-10.1 8319
3 EX-31.1 d83873dex311.htm EX-31.1 6999
4 EX-31.2 d83873dex312.htm EX-31.2 6989
5 EX-32.1 d83873dex321.htm EX-32.1 5031
  Complete submission text file 0001193125-20-286283.txt   4725463

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA mgta-20200930.xsd EX-101.SCH 26240
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mgta-20200930_cal.xml EX-101.CAL 31338
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mgta-20200930_def.xml EX-101.DEF 215559
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mgta-20200930_lab.xml EX-101.LAB 274748
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mgta-20200930_pre.xml EX-101.PRE 241262
11 EXTRACTED XBRL INSTANCE DOCUMENT d83873d10q_htm.xml XML 526819
Mailing Address 100 TECHNOLOGY SQUARE 5TH FLOOR CAMBRIDGE MA 02139
Business Address 100 TECHNOLOGY SQUARE 5TH FLOOR CAMBRIDGE MA 02139 857-201-2700
Magenta Therapeutics, Inc. (Filer) CIK: 0001690585 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38541 | Film No.: 201288826
SIC: 2834 Pharmaceutical Preparations